Search

everythinglearnresearchcommunity

for

Search:↓

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

A man with a rare skin condition and a new gene mutation developed high calcium levels due to his treatment.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

A woman with leprosy improved after stopping dapsone and getting treatment for a severe skin reaction and nail changes.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Wedelolactone may help treat lung fibrosis by reducing inflammation and lung damage.

Vitamin D3 is a safe and effective alternative to steroids for treating alopecia areata, with fewer side effects.

Spontaneous keloids may be linked to nephrogenic systemic fibrosis in dialysis patients.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

The combination of the excimer lamp and liquor carbonis detergens is more effective for scalp psoriasis than the lamp alone.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Intralesional vitamin D3 injections can improve vitamin D3 levels and may help treat alopecia areata.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

A new cream, DHMEQ, reduces allergic skin inflammation effectively.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

The 810-nm diode laser improves skin texture in keratosis pilaris but not redness.

Most children with skin inflammation taking methotrexate had lab abnormalities, but liver issues often improved without changing the medication dose.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Dithranol is more effective than Tacrolimus for hair regrowth in alopecia areata.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Transplantation is effective for stable leucoderma but not for progressive, widespread vitiligo vulgaris.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.